
Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis
Author(s) -
Ying Jin,
Yan Sun,
Xun Shi,
Jun Zhao,
Lei Shi,
Xin Yu
Publication year - 2014
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.145854
Subject(s) - medicine , meta analysis , hazard ratio , lung cancer , confidence interval , oncology , subgroup analysis , c reactive protein , gastroenterology , inflammation
The clinical and prognostic significance of C-reactive protein (CRP) in nonsmall-cell lung cancer (NSCLC) remains inconsistent. To clarify a precise determinant of the clinical significance of CRP, we conducted a systematic review and meta-analysis to evaluate the overall risk of elevated CRP for survival in NSCLC.